BRIEF published on 11/14/2025 at 16:26, 2 months 12 days ago Turkiye Garanti Bankasi publie un nouveau résumé du prospectus Relations Avec Les Investisseurs Banque Garanti Résumé Du Prospectus Approbation Des Marchés Financiers Délivrance De Mandat
BRIEF published on 11/14/2025 at 16:26, 2 months 12 days ago The Vanguard Group's Disclosure on American Axle & Manufacturing Holdings Acquisition Securities Disclosure Vanguard Group Shareholding American Axle
BRIEF published on 11/14/2025 at 16:26, 2 months 12 days ago Déclaration du groupe Vanguard concernant American Axle & Manufacturing Holdings Acquisition Actionnariat Groupe Vanguard Information Sur Les Valeurs Mobilières Essieu Américain
BRIEF published on 11/14/2025 at 16:25, 2 months 12 days ago The Vanguard Group Discloses Position in JTC plc Disclosure Takeover Code Vanguard Group Shareholding JTC Plc
BRIEF published on 11/14/2025 at 16:25, 2 months 12 days ago Le groupe Vanguard révèle sa participation dans JTC plc Actionnariat Groupe Vanguard Code De Prise De Contrôle Divulgation JTC Plc
BRIEF published on 11/14/2025 at 16:25, 2 months 12 days ago Hexaom Reports Nine-Month Revenue of EUR 442.9 Million for 2025 Real Estate Development Renovation HEXAOM Revenue Home Building Land Development
BRIEF published on 11/14/2025 at 16:25, 2 months 12 days ago Hexaom annonce un chiffre d'affaires de 442,9 millions d'euros pour les neuf premiers mois de 2025. Renovation Développement Immobilier Construction De Maisons Aménagement Du Territoire Revenus Hexaom
BRIEF published on 11/14/2025 at 16:24, 2 months 12 days ago The Vanguard Group's Disclosure on Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Vanguard Group Shareholding Avadel Pharmaceuticals
BRIEF published on 11/14/2025 at 16:24, 2 months 12 days ago Information communiquée par le groupe Vanguard sur Avadel Pharmaceuticals Actionnariat Groupe Vanguard Formulaire 8.3 Avadel Pharmaceuticals Panel Irlandais Des OPA
BRIEF published on 11/14/2025 at 16:22, 2 months 12 days ago The Vanguard Group Discloses Stake in Greencore Group Securities Stake Disclosure Vanguard Bakkavor Group Greencore Group
Published on 01/26/2026 at 15:42, 3 hours 2 minutes ago Greenlane to Deploy up to 30 Million Units of BERA Into Validator Infrastructure to Participate in Protocol-Level Yield Mechanisms, Bringing Total Validator Deployment to up to 50 Million Units
Published on 01/26/2026 at 15:30, 3 hours 14 minutes ago Silver Spruce Announces Director and Officer Resignation
Published on 01/26/2026 at 14:00, 4 hours 44 minutes ago Rare Earth Targets Refined as IP, MT, Radiometric and Geological Data Converge at Colosseum Project
Published on 01/26/2026 at 14:00, 4 hours 44 minutes ago Richter Extends Its Support to Africa - The First Year of the House of Hope in Bamako in Numbers
Published on 01/26/2026 at 13:45, 4 hours 59 minutes ago Quartz Announces Significant Induced Polarization Survey Results for Maestro Gold-Silver Project, British Columbia
Published on 01/26/2026 at 18:30, 14 minutes ago DocMorris repurchases convertible bonds maturing in 2026 with a nominal value of around CHF 14.4 million
Published on 01/26/2026 at 18:00, 44 minutes ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.12.25.
Published on 01/26/2026 at 17:59, 45 minutes ago PoPP draft specifications support seamless continuation of Redcare Pharmacy’s digital e-prescription journey.
Published on 01/26/2026 at 17:45, 59 minutes ago Dr. Christian Schlögel nominated as new member of the Board of Directors
Published on 01/26/2026 at 17:40, 1 hour 4 minutes ago VALBIOTIS SA: Valbiotis launches an exclusive commercial benefit for its shareholders: a 20% discount on ValbiotisPRO® and ValbiotisPLUS® ranges
Published on 01/26/2026 at 18:00, 44 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 20 et le 21 janvier 2026
Published on 01/26/2026 at 18:00, 44 minutes ago Reporting on share buyback transactions carried out between January 20 and January 21, 2026
Published on 01/26/2026 at 17:45, 59 minutes ago Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments
Published on 01/26/2026 at 17:45, 59 minutes ago Gimv verhoogt focus op strategische doelstellingen en discontinueert activiteiten voor nieuwe Life Sciences investeringen
Published on 01/26/2026 at 17:45, 59 minutes ago Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments
